Effect of deep breathing exercise with Triflo on dyspnoea, anxiety and quality of life in patients receiving covid‐19 treatment: A randomized controlled trial

Abstract

Aims and objectives Determination of the effect of deep breathing exercise applied with Triflo on dyspnoea, anxiety and quality of life in patients who are hospitalized for COVID‐19 and have dyspnoea. Backround COVID‐19 is a viral infection that can cause severe pulmonary disease. Deep breathing exercise with Triflo in patients with COVID‐19 may contribute to the reduction/elimination of dyspnoea and anxiety, and improvement of respiratory and quality of life. Design The study was a randomized controlled clinical trial and conducted in accordance with the Consolidated Standards of Reporting Trials (CONSORT) 2010 guidelines. Methods The study was conducted in the clinic of COVID‐19 of a tertiary hospital. A total of 44 eligible participants were enrolled from January to April 2021. Primary outcomes included oxygen saturation in the blood, respiratory assessment and dyspnoea level. Secondary outcomes included anxiety and quality of life. In the statistical analysis of the data, the independent sample t‐test, Wilcoxon test, Mann–Whitney U test and Spearman correlation were used to examine the intervention effect on primary outcomes and secondary outcomes, according to numbers, percentage, mean, standard deviation and conformity to normal distribution. Results It was determined that the patients in the deep breathing group had a statistically significant shorter hospitalization time (3.04 ± 0.65), higher SpO2 level (97.05 ± 1.46) and higher quality of life (77.82 ± 6.77) compared with the patients in the usual care group (p < 0.05). Conclusions Deep breathing exercise with Triflo increases the SpO2 level and quality of life in patients with COVID‐19 and contributes to a decrease in dyspnoea and anxiety levels. Moreover, the duration of hospital stay is shortened in patients who are applied deep breathing exercise with Triflo. Relevance to clinical practice With deep breathing exercise applied with Triflo, respiratory rate reaches normal limits in a short time, SpO2 levels increase significantly, and quality of life improves significantly in patients with COVID‐19 pneumonia. Clinical trials registration number https://clinicaltrials.gov; NCT04696562.

Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review

“…Most of the studies had been conducted in China ( n = 15) ( 30 , 33 , 34 , 45 , 50 , 52–55 , 63 , 64 , 66–69 ), Iran ( n = 6) ( 38 , 47 , 48 , 58 , 61 , 62 ), Italy ( n = 5) ( 29 , 31 , 41 , 44 , 57 ), India ( n = 4) ( 36 , 46 , 56 , 59 ), United States ( n = 2) ( 28 , 35 ), and Korea ( n = 2) ( 49 , 65 ). The remaining studies had been developed in Saudi Arabia ( n = 1) ( 27 ), Nigeria ( n = 1) ( 32 ), Indonesia ( n = 1) ( 39 ), France ( n = 1) ( 42 ), Turkey ( n = 1) ( 43 ), Thailand ( n = 1) ( 51 ), Latvia ( n = 1) ( 40 ), Ghana ( n = 1) ( 37 ), and Poland ( n = 1) ( 60 ).…”

Early physiotherapy management of patients with Covid‐19 admitted to a university hospital in Norway (March 2020 to July 2021)

“…Unfortunately, there were insufficient data related to the evaluation of these interventions. A recent small randomized controlled study in patients with Covid‐19 has shown that deep breathing exercise led to statistically significant shorter hospitalization, higher Sp0 2 levels and higher quality of life compared to usual care without respiratory physiotherapy (Oner Cengiz et al., 2022).…”

“…Effectiveness of respiratory physiotherapy treatment in patients admitted to ICU, has been demonstrated in some reviews (Tipping et al, 2017;Bernal-Utrera et al, 2021). In that deep breathing exercise led to statistically significant shorter hospitalization, higher Sp0 2 levels and higher quality of life compared to usual care without respiratory physiotherapy (Oner Cengiz et al, 2022).…”

The effectiveness of respiratory gymnastics and technologies of virtual reality and mechanotherapy in rehabilitation programs for patients with post-COVID syndrome

“…Перспективным методов видится дыхательная БОС, которая, считывая дыхательные движения, преобразовывает их в звуковые или визуальные сигналы, что облегчает контроль дыхания и осуществление техник респираторной реабилитации [77]. Исследования предполагают, что диафрагмальное дыхание БОС столь же эффективно, как и пропранолол, в облегчении мигренозных головных болей [78].…”